Long-term use of low molecular weight heparin for venous thromboembolism prophylaxis in French geriatric settings.
Trivalle
C
C
Medjahed
S
S
Belmin
J
J
D000368:Aged; D000369:Aged, 80 and over; D003625:Data Collection; D004334:Drug Administration Schedule; D005260:Female; D005602:France; D005853:Geriatrics / Q000379:methods; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage*; D006801:Humans; D008134:Long-Term Care; D008297:Male; D011322:Primary Prevention; D011379:Prognosis; D018570:Risk Assessment; D011795:Surveys and Questionnaires; D013923:Thromboembolism / Q000188:drug therapy* / Q000517:prevention & control*; D016896:Treatment Outcome
D006495:Heparin, Low-Molecular-Weight